ELVN - Company ID 0001672619
As of 2026-09-07, Enliven Therapeutics, Inc. (ELVN) has a market capitalization of $3.61 B, making it the #1684 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-07 | $3.61 B |
| 2026-09-06 | $3.61 B |
| 2026-09-05 | $3.61 B |
| 2026-09-04 | $3.61 B |
| 2026-09-03 | $3.61 B |
| 2026-09-02 | $3.59 B |
| 2026-09-01 | $3.50 B |
| 2026-08-31 | $3.53 B |
| 2026-08-30 | $3.52 B |
| 2026-08-29 | $3.52 B |
| 2026-08-28 | $3.52 B |
| 2026-08-27 | $3.68 B |
As of 2026-09-07, Enliven Therapeutics, Inc. (ELVN) has a market capitalization of $3.61 B, making it the #1684 most valuable US-listed company.
Enliven Therapeutics, Inc. is the #1684 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-26 | $3.74 B |
| 2026-08-25 | $3.72 B |
| 2026-08-24 | $3.72 B |
| 2026-08-23 | $3.64 B |
| 2026-08-22 | $3.64 B |
| 2026-08-21 | $3.64 B |
| 2026-08-20 | $3.59 B |
| 2026-08-19 | $3.62 B |
| 2026-08-18 | $3.66 B |
| 2026-08-17 | $3.63 B |
| 2026-08-16 | $3.58 B |
| 2026-08-15 | $3.58 B |
| 2026-08-14 | $3.58 B |
| 2026-08-13 | $3.54 B |
| 2026-08-12 | $3.53 B |
| 2026-08-11 | $3.58 B |
| 2026-08-10 | $3.64 B |
| 2026-08-09 | $3.68 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.